Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 GATA1s exerts developmental stage-specific effects in human hematopoiesis.

Literature DB >> 29567780

GATA1s exerts developmental stage-specific effects in human hematopoiesis.

Sofia Gialesaki¹, Anna Katharina Mahnken¹, Lena Schmid¹, Maurice Labuhn¹, Raj Bhayadia², Dirk Heckl³, Jan-Henning Klusmann⁴.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2018 PMID： 29567780 PMCID： PMC6068023 DOI： 10.3324/haematol.2018.191338

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

15 in total

1. Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis.

Authors: Jan-Henning Klusmann; Frank J Godinho; Kirsten Heitmann; Aliaksandra Maroz; Mia Lee Koch; Dirk Reinhardt; Stuart H Orkin; Zhe Li
Journal: Genes Dev Date: 2010-08-01 Impact factor: 11.361

2. Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21.

Authors: Anindita Roy; Gillian Cowan; Adam J Mead; Sarah Filippi; Georg Bohn; Aristeidis Chaidos; Oliver Tunstall; Jerry K Y Chan; Mahesh Choolani; Phillip Bennett; Sailesh Kumar; Deborah Atkinson; Josephine Wyatt-Ashmead; Ming Hu; Michael P H Stumpf; Katerina Goudevenou; David O'Connor; Stella T Chou; Mitchell J Weiss; Anastasios Karadimitris; Sten Eirik Jacobsen; Paresh Vyas; Irene Roberts
Journal: Proc Natl Acad Sci U S A Date: 2012-10-08 Impact factor: 11.205

3. Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.

Authors: Kate A Alford; Katarina Reinhardt; Catherine Garnett; Alice Norton; Katarina Böhmer; Christine von Neuhoff; Alexandra Kolenova; Emanuele Marchi; Jan-Henning Klusmann; Irene Roberts; Henrik Hasle; Dirk Reinhardt; Paresh Vyas
Journal: Blood Date: 2011-06-29 Impact factor: 22.113

4. Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome.

Authors: Kate A Alford; Amy Slender; Lesley Vanes; Zhe Li; Elizabeth M C Fisher; Dean Nizetic; Stuart H Orkin; Irene Roberts; Victor L J Tybulewicz
Journal: Blood Date: 2010-02-12 Impact factor: 22.113

5. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.

Authors: Jan-Henning Klusmann; Zhe Li; Katarina Böhmer; Aliaksandra Maroz; Mia Lee Koch; Stephan Emmrich; Frank J Godinho; Stuart H Orkin; Dirk Reinhardt
Journal: Genes Dev Date: 2010-03-01 Impact factor: 11.361

6. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.

Authors: Zhe Li; Frank J Godinho; Jan-Henning Klusmann; Mireia Garriga-Canut; Channing Yu; Stuart H Orkin
Journal: Nat Genet Date: 2005-05-15 Impact factor: 38.330

7. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells.

Authors: Glenn A Maclean; Tobias F Menne; Guoji Guo; Danielle J Sanchez; In-Hyun Park; George Q Daley; Stuart H Orkin
Journal: Proc Natl Acad Sci U S A Date: 2012-10-08 Impact factor: 11.205

8. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome.

Authors: Jan-Henning Klusmann; Ursula Creutzig; Martin Zimmermann; Michael Dworzak; Norbert Jorch; Claudia Langebrake; Arnulf Pekrun; Katarina Macakova-Reinhardt; Dirk Reinhardt
Journal: Blood Date: 2008-01-08 Impact factor: 22.113

9. CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo.

Authors: Jana Reimer; Sabine Knöß; Maurice Labuhn; Emmanuelle M Charpentier; Gudrun Göhring; Brigitte Schlegelberger; Jan-Henning Klusmann; Dirk Heckl
Journal: Haematologica Date: 2017-06-01 Impact factor: 9.941